SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* MONTREUX EQUITY PARTNERS II SBIC LP (Last) (First) (Middle) 2500 SAND HILL ROAD SUITE 215 (Street) MENLO PARK CA 94025 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Somaxon Pharmaceuticals, Inc. [ SOMX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 03/18/2010
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2010		S		1,500,000	D	$6.3824(1)	695,505	D(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* MONTREUX EQUITY PARTNERS II SBIC LP (Last) (First) (Middle) 2500 SAND HILL ROAD SUITE 215 (Street) MENLO PARK CA 94025 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* MONTREUX EQUITY MANAGEMENT II SBIC LLC (Last) (First) (Middle) 2500 SAND HILL ROAD 215 (Street) MENLO PARK CA 94025 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* MONTREUX EQUITY PARTNERS III SBIC L P (Last) (First) (Middle) (Street) (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Montreux Equity Managment III SBIC (Last) (First) (Middle) 3000 SAND HILL ROAD BUILDING 1, SUITE 260 (Street) MENLO PARK CA 94025 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* PALEFSKY HOWARD D (Last) (First) (Middle) 2700 SANA HILL ROAD (Street) MENLO PARK CA 94025 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* TURNER DANIEL K III (Last) (First) (Middle) 2500 SAND HILL ROAD 215 (Street) MENLO PARK CA 94025 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. The sale price reported in this Form 4 was between the range of $6.78 per share and $6.25 per share. Full information regarding the number of shares sold at each separate price will be provided to the Commission staff upon request.

2. The reported securities are owned directly by Montreux Equity Partners II SBIC, L.P., ("MEP II") and Montreux Equity Partners III SBIC, L.P, ("MEP III") and may be deemed to be beneficially owned indirectly by Montreux Equity Management II SBIC, LLC ("MEM II"), as general partner of MEP II and Montreux Equity Management III SBIC, LLC ("MEM III"), as general partner of MEP III. Each of MEM II and MEM III disclaims any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein. The managing members of MEM II and MEM III are Howard D. Palefsky and Daniel K. Turner III ("Managing Members"). Each of the Managing Members disclaims any beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.

	/s/ Daniel K. Turner III for Montreux Equity Partners II SBIC, LP by Montreux Equity Management II SBIC, LLC, it general partner	03/22/2010
	/s/ Daniel K. Turner III as Managing Member for Montreux Equity Management II SBIC, LLC	03/22/2010
	/s/ Daniel K. Turner III for Montreux Equity Partners III SBIC, LP by Montreux Equity Management III SBIC, LLC, it general partner	03/22/2010
	/s/ Daniel K. Turner III as Managing Member for Montreux Equity Management III SBIC, LLC	03/22/2010
	/s/ Howard D. Palefsky	03/22/2010
	/s/ Daniel K. Turner III	03/22/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.